Meredith Manning is Chief Commercial Officer of SOLENO THERAPEUTICS INC. Currently has a direct ownership of 53,600 shares of SLNO, which is worth approximately $2.73 Million. The most recent transaction as insider was on Jan 21, 2025, when has been sold 13,600 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 53.6K
34.0% 3M change
n/a 12M change
Total Value Held $2.73 Million

Meredith Manning Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 21 2025
BUY
Grant, award, or other acquisition
-
13,600 Added 20.24%
53,600 Common Stock
Jul 17 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 50.0%
40,000 Common Stock
MM

Meredith Manning

Chief Commercial Officer
Redwood City, CA

Track Institutional and Insider Activities on SLNO

Follow SOLENO THERAPEUTICS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SLNO shares.

Notify only if

Insider Trading

Get notified when an Soleno Therapeutics Inc insider buys or sells SLNO shares.

Notify only if

News

Receive news related to SOLENO THERAPEUTICS INC

Track Activities on SLNO